Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity
Medicines · 16.06.2020 · 7 (6) · 33
DOI: 10.3390/medicines7060033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicines, online erschienen am 16.06.2020. Verfasst von Davide Giuseppe Ribaldone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Turin, 10126 Turin, Italy. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), can be associated with several extra-intestinal manifestations requiring a multidisciplinary management both in terms of work-up and therapy. Oral lesions are common in patients with IBD, with a prevalence ranging from 5% to 50%. These can represent an oral location of IBD as well as a side-effect of drugs used to treat the intestinal disease. Oral manifestations, occurring in patients with IBD, can be divided in nonmalignant, specific, and non-specific ones, and malignant lesions. While there is undoubtedly a need to search for an IBD in patients with oral lesions associated with intestinal symptoms, the work-up of those with an exclusive oral lesion should be personalized. Fecal calprotectin is a non-invasive marker of intestinal inflammation and may be used to select which patients need to undergo endoscopic examination, thereby avoiding unnecessary investigations. The pharmacological armamentarium to treat oral lesions associated with IBD includes topical or systemic corticosteroids, immunosuppressive agents, and biologic drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
- Bow Lane Dental Group, St George's Hospital, Bupa Dental Care, London SW17 0QT, UK.
- Unit of Gastroenterology, Molinette Hospital, 10126 Turin, Italy.
ORCID-Profile: Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano
Zitieren
APA
Ribaldone, D. G., Brigo, S., Mangia, M., Saracco, G. M., Astegiano, M., & Pellicano, R. (2020). Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines, 7(6), 33. https://doi.org/10.3390/medicines7060033
Vancouver
Ribaldone DG, Brigo S, Mangia M, Saracco GM, Astegiano M, Pellicano R. Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines. 2020;7(6):33. doi:10.3390/medicines7060033
BibTeX
@article{Ribaldone2020,
author = {Ribaldone, Davide Giuseppe and Brigo, Selvaggia and Mangia, Michela and Saracco, Giorgio Maria and Astegiano, Marco and Pellicano, Rinaldo},
title = {Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity},
journal = {Medicines},
year = {2020},
volume = {7},
number = {6},
pages = {33},
doi = {10.3390/medicines7060033}
}
EUVIMED